Fluorescence Bioanalysis of Bevacizumab Using Pre-Column and Post-Column Derivatization – Liquid Chromatography After Immunoaffinity Magnetic Purification-Reference-Cited by-同舟云学术

Fluorescence Bioanalysis of Bevacizumab Using Pre-Column and Post-Column Derivatization – Liquid Chromatography After Immunoaffinity Magnetic Purification

Published:2020-10-20 Issue:3 Volume:41 Page:115-122
ISSN:1342-8284
Container-title:CHROMATOGRAPHY
language:en
Short-container-title:

Author:

TODOROKI Kenichiro¹,NAKANO Tatsuki¹,HAYASHI Hideki²,MIZUNO Hajime¹,Zhe MIN Jun³,TOYO’OKA Toshimasa¹

Affiliation:

1. School of Pharmaceutical Sciences, University of Shizuoka

2. Gifu Pharmaceutical University

3. College of Pharmacy, Yanbian University

Publisher

The Society for Chromatographic Sciences

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/jpchrom/41/3/41_2020.014/_pdf

Reference33 articles.

1. [1] Lobo, E. D.; Hansen, R. J.; Balthasar, J. P. J. Pharm. Sci. 2004, 93, 2645-2668.

2. [2] Wang, W.; Wang, E. Q.; Balthasar, J. P. Clin. Pharmacol. Ther. 2008, 84, 548-558.

3. [3] Van Cutsem, E.; Rivera, F.; Berry, S.; Kretzschmar, A.; Michael, M.; DiBartolomeo, M.; Mazier, M. A.; Canon, J. L.; Georgoulias, V.; Peeters, M.; Bridgewater, J.; Cunningham, D.; First, B. I. Ann. Oncol. 2009, 20, 1842-1847.

4. [4] Heinemann, V.; von Weikersthal, L. F.; Decker, T.; Kiani, A.; Vehling-Kaiser, U.; Al-Batran, S. -E.; Heintges, T.; Lerchenmueller, C.; Kahl, C.; Seipelt, G.; Kullmann, F.; Stauch, M.; Scheithauer, W.; Hielscher, J.; Scholz, M.; Mueller, S.; Link, H.; Niederle, N.; Rost, A.; Hoeffkes, H. -G.; Moehler, M.; Lindig, R. U.; Modest, D. P.; Rossius, L.; Kirchner, T.; Jung, A.; Stintzing, S. Lancet Oncol. 2014, 15, 1065-1075.

5. [5] Gordon, M. S.; Margolin, K.; Talpaz, M.; Sledge, G. W.; Holmgren, E.; Benjamin, R.; Stalter, S.; Shak, S.; Adelman, D. C. J. Clin. Oncol. 2001, 19, 843-850.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of Novel Separation and Analytical Methods for Optically Active Substances and Therapeutic Monoclonal Antibodies Based on Liquid Chromatography;CHROMATOGRAPHY;2024-02-20

2. Synchronous Fluorescence Method for Determination of Bevacizumab and Fluorouracil in Laboratory Prepared Mixture, Pharmaceutical Dosage Forms and Spiked Plasma;Analytical Chemistry Letters;2022-07-04